APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neratinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neratinib Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchNeratinib Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Neratinib Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Neratinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neratinib Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Neratinib Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Neratinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neratinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neratinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neratinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neratinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Neratinib include Puma Biotechnology and Beacon Pharmaceuticals Limited etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neratinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neratinib, also provides the sales of main regions and countries. Of the upcoming market potential for Neratinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neratinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neratinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neratinib sales, projected growth trends, production technology, application and end-user industry.

Neratinib Segment by Company

Puma Biotechnology

Beacon Pharmaceuticals Limited

Neratinib Segment by Type

40mg/90 Tablets

40mg/180 Tablets

40mg/150 Tablets

Neratinib Segment by Application

Early Breast Cancer

Others

Neratinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neratinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neratinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neratinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neratinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neratinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neratinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neratinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 40mg/90 Tablets Major Manufacturers Table 3. 40mg/180 Tablets Major Manufacturers Table 4. 40mg/150 Tablets Major Manufacturers Table 5. Global Neratinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Early Breast Cancer Major Manufacturers Table 7. Others Major Manufacturers Table 8. Neratinib Industry Trends Table 9. Neratinib Industry Drivers Table 10. Neratinib Industry Opportunities and Challenges Table 11. Neratinib Industry Restraints Table 12. Global Neratinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Neratinib Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Neratinib Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Neratinib Revenue Market Share by Region (2021-2026) Table 16. Global Neratinib Revenue Market Share by Region (2027-2032) Table 17. Global Neratinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 18. Global Neratinib Sales by Region (2021-2026) & (k pcs) Table 19. Global Neratinib Sales by Region (2027-2032) & (k pcs) Table 20. Global Neratinib Sales Market Share by Region (2021-2026) Table 21. Global Neratinib Sales Market Share by Region (2027-2032) Table 22. Global Neratinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Neratinib Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Neratinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Neratinib Sales Market Share by Manufacturers (2021-2026) Table 26. Global Neratinib Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 27. Global Neratinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Neratinib Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Neratinib Manufacturers, Product Type & Application Table 30. Global Neratinib Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Neratinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Neratinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Neratinib Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Neratinib Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Neratinib Revenue Market Share by Type (2021-2026) Table 37. Global Neratinib Revenue Market Share by Type (2027-2032) Table 38. Global Neratinib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 39. Global Neratinib Sales by Type (2021-2026) & (k pcs) Table 40. Global Neratinib Sales by Type (2027-2032) & (k pcs) Table 41. Global Neratinib Sales Market Share by Type (2021-2026) Table 42. Global Neratinib Sales Market Share by Type (2027-2032) Table 43. Global Neratinib Price by Type (2021-2026) & (US$/pcs) Table 44. Global Neratinib Price by Type (2027-2032) & (US$/pcs) Table 45. Global Neratinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Neratinib Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Neratinib Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Neratinib Revenue Market Share by Application (2021-2026) Table 49. Global Neratinib Revenue Market Share by Application (2027-2032) Table 50. Global Neratinib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 51. Global Neratinib Sales by Application (2021-2026) & (k pcs) Table 52. Global Neratinib Sales by Application (2027-2032) & (k pcs) Table 53. Global Neratinib Sales Market Share by Application (2021-2026) Table 54. Global Neratinib Sales Market Share by Application (2027-2032) Table 55. Global Neratinib Price by Application (2021-2026) & (US$/pcs) Table 56. Global Neratinib Price by Application (2027-2032) & (US$/pcs) Table 57. Puma Biotechnology Company Information Table 58. Puma Biotechnology Business Overview Table 59. Puma Biotechnology Neratinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 60. Puma Biotechnology Neratinib Product Portfolio Table 61. Puma Biotechnology Recent Development Table 62. Beacon Pharmaceuticals Limited Company Information Table 63. Beacon Pharmaceuticals Limited Business Overview Table 64. Beacon Pharmaceuticals Limited Neratinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 65. Beacon Pharmaceuticals Limited Neratinib Product Portfolio Table 66. Beacon Pharmaceuticals Limited Recent Development Table 67. North America Neratinib Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Neratinib Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Neratinib Sales by Type (2021-2026) & (k pcs) Table 70. North America Neratinib Sales by Type (2027-2032) & (k pcs) Table 71. North America Neratinib Sales Price by Type (2021-2026) & (US$/pcs) Table 72. North America Neratinib Sales Price by Type (2027-2032) & (US$/pcs) Table 73. North America Neratinib Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Neratinib Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Neratinib Sales by Application (2021-2026) & (k pcs) Table 76. North America Neratinib Sales by Application (2027-2032) & (k pcs) Table 77. North America Neratinib Sales Price by Application (2021-2026) & (US$/pcs) Table 78. North America Neratinib Sales Price by Application (2027-2032) & (US$/pcs) Table 79. North America Neratinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Neratinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Neratinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Neratinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 83. North America Neratinib Sales by Country (2021-2026) & (k pcs) Table 84. North America Neratinib Sales by Country (2027-2032) & (k pcs) Table 85. North America Neratinib Sales Price by Country (2021-2026) & (US$/pcs) Table 86. North America Neratinib Sales Price by Country (2027-2032) & (US$/pcs) Table 87. United States Neratinib Revenue (2021-2032) & (US$ Million) Table 88. Canada Neratinib Revenue (2021-2032) & (US$ Million) Table 89. Mexico Neratinib Revenue (2021-2032) & (US$ Million) Table 90. Europe Neratinib Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Neratinib Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Neratinib Sales by Type (2021-2026) & (k pcs) Table 93. Europe Neratinib Sales by Type (2027-2032) & (k pcs) Table 94. Europe Neratinib Sales Price by Type (2021-2026) & (US$/pcs) Table 95. Europe Neratinib Sales Price by Type (2027-2032) & (US$/pcs) Table 96. Europe Neratinib Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Neratinib Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Neratinib Sales by Application (2021-2026) & (k pcs) Table 99. Europe Neratinib Sales by Application (2027-2032) & (k pcs) Table 100. Europe Neratinib Sales Price by Application (2021-2026) & (US$/pcs) Table 101. Europe Neratinib Sales Price by Application (2027-2032) & (US$/pcs) Table 102. Europe Neratinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Neratinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Neratinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Neratinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 106. Europe Neratinib Sales by Country (2021-2026) & (k pcs) Table 107. Europe Neratinib Sales by Country (2027-2032) & (k pcs) Table 108. Europe Neratinib Sales Price by Country (2021-2026) & (US$/pcs) Table 109. Europe Neratinib Sales Price by Country (2027-2032) & (US$/pcs) Table 110. Germany Neratinib Revenue (2021-2032) & (US$ Million) Table 111. France Neratinib Revenue (2021-2032) & (US$ Million) Table 112. U.K. Neratinib Revenue (2021-2032) & (US$ Million) Table 113. Italy Neratinib Revenue (2021-2032) & (US$ Million) Table 114. Russia Neratinib Revenue (2021-2032) & (US$ Million) Table 115. Spain Neratinib Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Neratinib Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Neratinib Revenue (2021-2032) & (US$ Million) Table 118. Sweden Neratinib Revenue (2021-2032) & (US$ Million) Table 119. Poland Neratinib Revenue (2021-2032) & (US$ Million) Table 120. China Neratinib Revenue by Type (2021-2026) & (US$ Million) Table 121. China Neratinib Revenue by Type (2027-2032) & (US$ Million) Table 122. China Neratinib Sales by Type (2021-2026) & (k pcs) Table 123. China Neratinib Sales by Type (2027-2032) & (k pcs) Table 124. China Neratinib Sales Price by Type (2021-2026) & (US$/pcs) Table 125. China Neratinib Sales Price by Type (2027-2032) & (US$/pcs) Table 126. China Neratinib Revenue by Application (2021-2026) & (US$ Million) Table 127. China Neratinib Revenue by Application (2027-2032) & (US$ Million) Table 128. China Neratinib Sales by Application (2021-2026) & (k pcs) Table 129. China Neratinib Sales by Application (2027-2032) & (k pcs) Table 130. China Neratinib Sales Price by Application (2021-2026) & (US$/pcs) Table 131. China Neratinib Sales Price by Application (2027-2032) & (US$/pcs) Table 132. Asia Neratinib Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Neratinib Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Neratinib Sales by Type (2021-2026) & (k pcs) Table 135. Asia Neratinib Sales by Type (2027-2032) & (k pcs) Table 136. Asia Neratinib Sales Price by Type (2021-2026) & (US$/pcs) Table 137. Asia Neratinib Sales Price by Type (2027-2032) & (US$/pcs) Table 138. Asia Neratinib Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Neratinib Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Neratinib Sales by Application (2021-2026) & (k pcs) Table 141. Asia Neratinib Sales by Application (2027-2032) & (k pcs) Table 142. Asia Neratinib Sales Price by Application (2021-2026) & (US$/pcs) Table 143. Asia Neratinib Sales Price by Application (2027-2032) & (US$/pcs) Table 144. Asia Neratinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Neratinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Neratinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Neratinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 148. Asia Neratinib Sales by Country (2021-2026) & (k pcs) Table 149. Asia Neratinib Sales by Country (2027-2032) & (k pcs) Table 150. Asia Neratinib Sales Price by Country (2021-2026) & (US$/pcs) Table 151. Asia Neratinib Sales Price by Country (2027-2032) & (US$/pcs) Table 152. Japan Neratinib Revenue (2021-2032) & (US$ Million) Table 153. South Korea Neratinib Revenue (2021-2032) & (US$ Million) Table 154. India Neratinib Revenue (2021-2032) & (US$ Million) Table 155. Australia Neratinib Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Neratinib Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Neratinib Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Neratinib Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Neratinib Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Neratinib Sales by Type (2021-2026) & (k pcs) Table 161. SAMEA Neratinib Sales by Type (2027-2032) & (k pcs) Table 162. SAMEA Neratinib Sales Price by Type (2021-2026) & (US$/pcs) Table 163. SAMEA Neratinib Sales Price by Type (2027-2032) & (US$/pcs) Table 164. SAMEA Neratinib Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Neratinib Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Neratinib Sales by Application (2021-2026) & (k pcs) Table 167. SAMEA Neratinib Sales by Application (2027-2032) & (k pcs) Table 168. SAMEA Neratinib Sales Price by Application (2021-2026) & (US$/pcs) Table 169. SAMEA Neratinib Sales Price by Application (2027-2032) & (US$/pcs) Table 170. SAMEA Neratinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Neratinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Neratinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Neratinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 174. SAMEA Neratinib Sales by Country (2021-2026) & (k pcs) Table 175. SAMEA Neratinib Sales by Country (2027-2032) & (k pcs) Table 176. SAMEA Neratinib Sales Price by Country (2021-2026) & (US$/pcs) Table 177. SAMEA Neratinib Sales Price by Country (2027-2032) & (US$/pcs) Table 178. Brazil Neratinib Revenue (2021-2032) & (US$ Million) Table 179. Argentina Neratinib Revenue (2021-2032) & (US$ Million) Table 180. Chile Neratinib Revenue (2021-2032) & (US$ Million) Table 181. Colombia Neratinib Revenue (2021-2032) & (US$ Million) Table 182. Peru Neratinib Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Neratinib Revenue (2021-2032) & (US$ Million) Table 184. Israel Neratinib Revenue (2021-2032) & (US$ Million) Table 185. UAE Neratinib Revenue (2021-2032) & (US$ Million) Table 186. Turkey Neratinib Revenue (2021-2032) & (US$ Million) Table 187. Iran Neratinib Revenue (2021-2032) & (US$ Million) Table 188. Egypt Neratinib Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Neratinib Distributors List Table 192. Neratinib Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Neratinib Image Figure 2. Global Neratinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neratinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 40mg/90 Tablets Image Figure 5. 40mg/180 Tablets Image Figure 6. 40mg/150 Tablets Image Figure 7. Global Neratinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Neratinib Market Size Share 2021 VS 2025 VS 2032 Figure 9. Early Breast Cancer Image Figure 10. Others Image Figure 11. Global Neratinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Neratinib Revenue (2021-2032) & (US$ Million) Figure 13. Global Neratinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Neratinib Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Neratinib Revenue Market Share by Region (2021-2032) Figure 16. Global Neratinib Sales (2021-2032) & (k pcs) Figure 17. Global Neratinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 18. Global Neratinib Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Neratinib Sales YoY (2021-2032) & (k pcs) Figure 20. Europe Neratinib Sales YoY (2021-2032) & (k pcs) Figure 21. China Neratinib Sales YoY (2021-2032) & (k pcs) Figure 22. Asia (Excluding China) Neratinib Sales YoY (2021-2032) & (k pcs) Figure 23. South America, Middle East and Africa Neratinib Sales YoY (2021-2032) & (k pcs) Figure 24. Global Neratinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Neratinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Neratinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Neratinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Neratinib Revenue Market Share by Type (2021-2032) Figure 30. Global Neratinib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 31. Global Neratinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Neratinib Sales Market Share by Type (2021-2032) Figure 33. Global Neratinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Neratinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Neratinib Revenue Market Share by Application (2021-2032) Figure 36. Global Neratinib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 37. Global Neratinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Neratinib Sales Market Share by Application (2021-2032) Figure 39. North America Neratinib Revenue Share by Type (2021-2032) Figure 40. North America Neratinib Sales Share by Type (2021-2032) Figure 41. North America Neratinib Revenue Share by Application (2021-2032) Figure 42. North America Neratinib Sales Share by Application (2021-2032) Figure 43. North America Neratinib Revenue Share by Country (2021-2032) Figure 44. North America Neratinib Sales Share by Country (2021-2032) Figure 45. Europe Neratinib Revenue Share by Type (2021-2032) Figure 46. Europe Neratinib Sales Share by Type (2021-2032) Figure 47. Europe Neratinib Revenue Share by Application (2021-2032) Figure 48. Europe Neratinib Sales Share by Application (2021-2032) Figure 49. Europe Neratinib Revenue Share by Country (2021-2032) Figure 50. Europe Neratinib Sales Share by Country (2021-2032) Figure 51. China Neratinib Revenue Share by Type (2021-2032) Figure 52. China Neratinib Sales Share by Type (2021-2032) Figure 53. China Neratinib Revenue Share by Application (2021-2032) Figure 54. China Neratinib Sales Share by Application (2021-2032) Figure 55. Asia Neratinib Revenue Share by Type (2021-2032) Figure 56. Asia Neratinib Sales Share by Type (2021-2032) Figure 57. Asia Neratinib Revenue Share by Application (2021-2032) Figure 58. Asia Neratinib Sales Share by Application (2021-2032) Figure 59. Asia Neratinib Revenue Share by Country (2021-2032) Figure 60. Asia Neratinib Sales Share by Country (2021-2032) Figure 61. SAMEA Neratinib Revenue Share by Type (2021-2032) Figure 62. SAMEA Neratinib Sales Share by Type (2021-2032) Figure 63. SAMEA Neratinib Revenue Share by Application (2021-2032) Figure 64. SAMEA Neratinib Sales Share by Application (2021-2032) Figure 65. SAMEA Neratinib Revenue Share by Country (2021-2032) Figure 66. SAMEA Neratinib Sales Share by Country (2021-2032) Figure 67. Neratinib Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Neratinib Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg/90 Tablets
  • 40mg/180 Tablets
  • 40mg/150 Tablets
Applications
  • Early Breast Cancer
  • Others
Companies covered
  • Puma Biotechnology
  • Beacon Pharmaceuticals Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neratinib Market by Type
  3. 1.2.1 Global Neratinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 40mg/90 Tablets
  5. 1.2.3 40mg/180 Tablets
  6. 1.2.4 40mg/150 Tablets
  7. 1.3 Neratinib Market by Application
  8. 1.3.1 Global Neratinib Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Early Breast Cancer
  10. 1.3.3 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Neratinib Market Dynamics
  1. 2.1 Neratinib Industry Trends
  2. 2.2 Neratinib Industry Drivers
  3. 2.3 Neratinib Industry Opportunities and Challenges
  4. 2.4 Neratinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neratinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neratinib Revenue by Region
  3. 3.2.1 Global Neratinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neratinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Neratinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Neratinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neratinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neratinib Sales by Region
  9. 3.4.1 Global Neratinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neratinib Sales by Region (2021-2026)
  11. 3.4.3 Global Neratinib Sales by Region (2027-2032)
  12. 3.4.4 Global Neratinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neratinib Revenue by Manufacturers
  2. 4.1.1 Global Neratinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neratinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neratinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neratinib Sales by Manufacturers
  6. 4.2.1 Global Neratinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neratinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neratinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neratinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neratinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neratinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neratinib Manufacturers, Product Type & Application
  13. 4.7 Global Neratinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neratinib Market CR5 and HHI
  16. 4.8.2 2025 Neratinib Tier 1, Tier 2, and Tier 3
5 Neratinib Market by Type
  1. 5.1 Global Neratinib Revenue by Type
  2. 5.1.1 Global Neratinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neratinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neratinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neratinib Sales by Type
  6. 5.2.1 Global Neratinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neratinib Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Neratinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neratinib Price by Type
6 Neratinib Market by Application
  1. 6.1 Global Neratinib Revenue by Application
  2. 6.1.1 Global Neratinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neratinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neratinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neratinib Sales by Application
  6. 6.2.1 Global Neratinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neratinib Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Neratinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neratinib Price by Application
7 Company Profiles
  1. 7.1 Puma Biotechnology
  2. 7.1.1 Puma Biotechnology Company Information
  3. 7.1.2 Puma Biotechnology Business Overview
  4. 7.1.3 Puma Biotechnology Neratinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Puma Biotechnology Neratinib Product Portfolio
  6. 7.1.5 Puma Biotechnology Recent Developments
  7. 7.2 Beacon Pharmaceuticals Limited
  8. 7.2.1 Beacon Pharmaceuticals Limited Company Information
  9. 7.2.2 Beacon Pharmaceuticals Limited Business Overview
  10. 7.2.3 Beacon Pharmaceuticals Limited Neratinib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Beacon Pharmaceuticals Limited Neratinib Product Portfolio
  12. 7.2.5 Beacon Pharmaceuticals Limited Recent Developments
8 North America
  1. 8.1 North America Neratinib Market Size by Type
  2. 8.1.1 North America Neratinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Neratinib Sales by Type (2021-2032)
  4. 8.1.3 North America Neratinib Price by Type (2021-2032)
  5. 8.2 North America Neratinib Market Size by Application
  6. 8.2.1 North America Neratinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Neratinib Sales by Application (2021-2032)
  8. 8.2.3 North America Neratinib Price by Application (2021-2032)
  9. 8.3 North America Neratinib Market Size by Country
  10. 8.3.1 North America Neratinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neratinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neratinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Neratinib Market Size by Type
  2. 9.1.1 Europe Neratinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neratinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Neratinib Price by Type (2021-2032)
  5. 9.2 Europe Neratinib Market Size by Application
  6. 9.2.1 Europe Neratinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neratinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Neratinib Price by Application (2021-2032)
  9. 9.3 Europe Neratinib Market Size by Country
  10. 9.3.1 Europe Neratinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neratinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neratinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Neratinib Market Size by Type
  2. 10.1.1 China Neratinib Revenue by Type (2021-2032)
  3. 10.1.2 China Neratinib Sales by Type (2021-2032)
  4. 10.1.3 China Neratinib Price by Type (2021-2032)
  5. 10.2 China Neratinib Market Size by Application
  6. 10.2.1 China Neratinib Revenue by Application (2021-2032)
  7. 10.2.2 China Neratinib Sales by Application (2021-2032)
  8. 10.2.3 China Neratinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neratinib Market Size by Type
  2. 11.1.1 Asia Neratinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neratinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Neratinib Price by Type (2021-2032)
  5. 11.2 Asia Neratinib Market Size by Application
  6. 11.2.1 Asia Neratinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neratinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Neratinib Price by Application (2021-2032)
  9. 11.3 Asia Neratinib Market Size by Country
  10. 11.3.1 Asia Neratinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neratinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neratinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neratinib Market Size by Type
  2. 12.1.1 SAMEA Neratinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neratinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neratinib Price by Type (2021-2032)
  5. 12.2 SAMEA Neratinib Market Size by Application
  6. 12.2.1 SAMEA Neratinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neratinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neratinib Price by Application (2021-2032)
  9. 12.3 SAMEA Neratinib Market Size by Country
  10. 12.3.1 SAMEA Neratinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neratinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neratinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neratinib Value Chain Analysis
  2. 13.1.1 Neratinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neratinib Production Mode & Process
  6. 13.2 Neratinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neratinib Distributors
  9. 13.2.3 Neratinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst